Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Edelmann

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
Frontiers in Cardiovascular Medicine|December 17, 2020
A Random Shuffle Method to Expand a Narrow Dataset and Overcome the Associated Challenges in a Clinical Study: A Heart Failure Cohort ExampleLorenzo Fassina, Alessandro Faragli, Francesco Paolo Lo Muzio, et al.
Clinical Cardiology|May 4, 2017
Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart FailureClaus Lüers, Frank Edelmann, Rolf Wachter, et al.
European Journal of Epidemiology|February 21, 2026
Authors' reply: "Chronic high consumption of energy drinks and cardiovascular risk in adolescents-results of the EDKAR-study"Juliane Menzel, Fabian Spinka, Maria J Pie, et al.
International Journal of Cardiology|June 27, 2008
The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessmentMartin Braun, Frank Edelmann, Markus Knapp, et al.
International Journal of Cardiology. Heart & Vasculature|June 16, 2017
NT-proBNP and diastolic left ventricular function in patients with Marfan syndromePetra Gehle, Peter N Robinson, Frank Heinzel, et al.
European Journal of Epidemiology|August 23, 2025
Chronic high consumption of energy drinks and cardiovascular risk in adolescents-results of the EDKAR-studyJuliane Menzel, Fabian Spinka, Maria J Pie, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 14, 2020
Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysisPeter McGranaghan, Anshul Saxena, Muni Rubens, et al.
Ebiomedicine|September 9, 2023
Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trialsKarl-Patrik Kresoja, Matthias Unterhuber, Rolf Wachter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2021
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trialKatharina Lechner, Johannes Scherr, Elke Lorenz, et al.
Bioengineering (Basel, Switzerland)|October 29, 2025
In Silico and In Vitro Comparison of Seven Closed and Semi-Closed Leaflet Designs for Transcatheter Heart Valve ReplacementsAlexander Breitenstein-Attach, Marvin Steitz, Jordi Modolell, et al.
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
Frontiers in Cardiovascular Medicine|December 17, 2020
A Random Shuffle Method to Expand a Narrow Dataset and Overcome the Associated Challenges in a Clinical Study: A Heart Failure Cohort ExampleLorenzo Fassina, Alessandro Faragli, Francesco Paolo Lo Muzio, et al.
Clinical Cardiology|May 4, 2017
Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart FailureClaus Lüers, Frank Edelmann, Rolf Wachter, et al.
European Journal of Epidemiology|February 21, 2026
Authors' reply: "Chronic high consumption of energy drinks and cardiovascular risk in adolescents-results of the EDKAR-study"Juliane Menzel, Fabian Spinka, Maria J Pie, et al.
International Journal of Cardiology|June 27, 2008
The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessmentMartin Braun, Frank Edelmann, Markus Knapp, et al.
International Journal of Cardiology. Heart & Vasculature|June 16, 2017
NT-proBNP and diastolic left ventricular function in patients with Marfan syndromePetra Gehle, Peter N Robinson, Frank Heinzel, et al.
European Journal of Epidemiology|August 23, 2025
Chronic high consumption of energy drinks and cardiovascular risk in adolescents-results of the EDKAR-studyJuliane Menzel, Fabian Spinka, Maria J Pie, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 14, 2020
Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysisPeter McGranaghan, Anshul Saxena, Muni Rubens, et al.
Ebiomedicine|September 9, 2023
Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trialsKarl-Patrik Kresoja, Matthias Unterhuber, Rolf Wachter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2021
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trialKatharina Lechner, Johannes Scherr, Elke Lorenz, et al.
Bioengineering (Basel, Switzerland)|October 29, 2025
In Silico and In Vitro Comparison of Seven Closed and Semi-Closed Leaflet Designs for Transcatheter Heart Valve ReplacementsAlexander Breitenstein-Attach, Marvin Steitz, Jordi Modolell, et al.
Pageof 22